What happened with SXTC today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
China SXT Pharmaceuticals earns most of its revenue from Regular TCMP—traditional Chinese medicine pieces used for treatment or as dietary supplements. Hospitals, especially traditional Chinese medicine hospitals, buy its products directly, while pharmaceutical wholesalers and distributors buy them to supply hospitals and other healthcare distributors. A smaller product line, Advanced TCMP, can be taken directly by mouth or after soaking in hot water, without boiling into a decoction.
One customer supplies the vast majority of revenue, so the business depends heavily on retaining that relationship. Manufacturing requires valid pharmaceutical permits and continued compliance with Good Manufacturing Practice inspections. Some products also face government-set retail-price ceilings, which limit pricing without necessarily limiting production costs.
The listed company is an offshore holding company. It conducts its Chinese operations through subsidiaries and contractual arrangements with Taizhou Suxuantang, rather than owning shares in that operating company. Its control of the business and access to its economic benefits therefore depend on those agreements remaining enforceable.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
China SXT’s results hinge on Chinese hospital and distributor demand for traditional Chinese medicine pieces and pricing competition from Kangmei, CTCM and Xiangxue, none of which appears on this list.
Universe Pharmaceuticals overlaps with China SXT by making Chinese medicines and selling third-party traditional Chinese medicine pieces in China, while China SXT sells its own pieces mainly to hospitals and pharmaceutical distributors. Universe’s sales of third-party pieces are the part of its business to watch for competition with China SXT.
No upcoming items to show.
Earnings, filings and other dated events show up here once their dates are set.
